Emerging role of Natural killer cells in oncolytic virotherapy

about

Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.Fighting Cancer with Mathematics and Viruses.

P2860

Q38400073-E962DAFC-1E70-48CD-BF83-2E137E3EFFF7 Q38612646-38E43806-F5C5-49F2-B90C-8B5BD2452C2F

P2860

Emerging role of Natural killer cells in oncolytic virotherapy

Item

http://www.wikidata.org/entity/Q27025330

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Emerging role of Natural killer cells in oncolytic virotherapy

@ast

Emerging role of Natural killer cells in oncolytic virotherapy

@en

Emerging role of Natural killer cells in oncolytic virotherapy

@nl

type

Item

label

Emerging role of Natural killer cells in oncolytic virotherapy

@ast

Emerging role of Natural killer cells in oncolytic virotherapy

@en

Emerging role of Natural killer cells in oncolytic virotherapy

@nl

prefLabel

Emerging role of Natural killer cells in oncolytic virotherapy

@ast

Emerging role of Natural killer cells in oncolytic virotherapy

@en

Emerging role of Natural killer cells in oncolytic virotherapy

@nl

P1476

Emerging role of Natural killer cells in oncolytic virotherapy

@en

P2093

Jean Rommelaere

http://www.w3.org/2001/XMLSchema#string

Rauf Bhat

http://www.w3.org/2001/XMLSchema#string

P2860

Thunder and lightning: immunotherapy and oncolytic viruses collide

Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment

Advantages and clinical applications of natural killer cells in cancer immunotherapy

Oncolytic viruses as anticancer vaccines

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame

Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.

Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1

Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.

P304

65-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/ITT.S55549

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27471713

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4918259

http://www.w3.org/2001/XMLSchema#string

Emerging role of Natural killer cells in oncolytic virotherapy

about

P2860

P2860

Emerging role of Natural killer cells in oncolytic virotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932